Making Personalized Medicine Boring: Why That’s the Goal w/ Dr. Ryan Nelson

In this episode of The Promise of Personalized Medicine, Perry sits down with Dr. Ryan Nelson, to explore the evolving and sometimes misunderstood world of personalized medicine. With years of hands-on experience, Dr. Nelson offers a refreshingly nuanced definition—one that goes beyond genetics to include biomarkers, digital tools, and system-wide collaboration for predictive, preventative, and precisely tailored care.We dive deep into:the challenges and slow adoption of pharmacogenetics in the U.S.the ethical and regulatory friction surrounding genetic testingwhy "genetic exceptionalism" may actually hinder progressthe FDA’s shifting role to real-world cost savings dataRyan also shares a behind-the-scenes look at MetaCensus, a new distributed platform designed to foster consensus among stakeholders through open-access, federated data—creating space for payers, providers, pharma, and regulators to weigh evidence transparently.—-------Stay connected with our host, Perry Dimas, here on LinkedIn! 📧 Interested in joining our medical director advisory group? Email us at [email protected] 🔗 Connect on LinkedIn: linkedin.com/company/accessdx